What Biostarks does

Biostarks is a Swiss direct-to-consumer biomarker testing company, headquartered in Vevey and operating as a division of AMR Labs SA since its 2025 acquisition. It sells at-home dried blood spot test panels—Nutrition ($199, 30+ biomarkers), Longevity NAD+ ($199), Metabolic Health ($299, 39+ biomarkers), and Sport Performance ($199, currently sold out)—to health-conscious consumers, athletes, GLP-1 / weight-management users, and longevity-focused individuals. Samples are collected at home via a finger-prick kit and shipped via pre-paid envelopes to Biostarks' CLIA-certified laboratory in Switzerland (Registration Id 99D2335130), where they are analyzed on a high-resolution mass spectrometry platform spanning LC-MS/MS, GC-MS, and ICP-MS instrumentation. Results are returned within 5–10 days as personalized wellness reports generated through AI-assisted interpretation, with FSA/HSA eligibility and tiered bulk discounts (10% off 2+ kits, 15% off 3+ kits).

The company's commercial model rests on three revenue pillars: direct e-commerce sales of one-time test kits, affiliate/co-marketing revenue with supplement partners (Solgar and Nestlé Health Science), and emerging B2B channels served through dedicated /for-professionals and /for-employers pages targeting nutritionists, dietitians, longevity clinics, sport coaches, and corporate wellness programs. Distribution is anchored on the company's own Shopify storefront with global shipping, supplemented by select retailers, a Geneva logistics facility, and a French distribution hub in Annemasse. A 2026 platform extension called Open Labs allows users to import third-party lab reports via PDF or HL7 and maps them against a 700+ biomarker library, broadening the product surface from a closed lab service toward a biomarker data hub.

Biostarks claims 100,000+ tests performed and 8,000+ customers with a 4.78 rating across 479 reviews, and it cites an internal figure of 88% of users uncovering at least one actionable insight. Headcount is reported at 11–50 employees, and the company has assembled a Scientific Committee headed by Professor Gérard Hopfgartner. The business is privately held; no venture or growth funding rounds are disclosed, ownership now resides with AMR Labs SA, and European regulatory posture is reinforced by GDPR and EU AI Act disclosures (limited/minimal risk classification).

Name

Biostarks

Legal name

AMR Labs SA

Website

https://biostarks.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Biostarks is a Swiss direct-to-consumer biomarker testing company operating its own CLIA-certified mass spectrometry laboratory. It sells at-home dried blood spot panels (Nutrition, Longevity NAD+, Metabolic Health, Sport Performance) to health-conscious consumers, athletes, GLP-1 users, and longevity-focused individuals, with flagship partnerships with Solgar and Nestlé Health Science.

Ownership category

akta.pro rank

Product category

At-Home Diagnostic Testing

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Proteomics & Biomarker Analytical Testing (HLAGADAG)

akta.pro secondary industry

Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

• At-home biomarker testing
• Dried blood spot analysis
• Mass spectrometry diagnostics
• Personalized wellness insights
• Preventive health screening

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Biomarker Test Kit Sales: One-time purchase revenue from at-home biomarker testing kits. Products include Nutrition Panel ($199), Longevity NAD+ ($199), Metabolic Health ($299), and Sport Performance ($199). Revenue is generated through direct e-commerce sales on the company website with tiered volume discounts (10% off for 2+ kits, 15% off for 3+ kits). FSA/HSA eligible payments supported.
2. Supplement Partnership Revenue (Solgar): Commercial collaboration with Solgar generates revenue through biomarker-guided supplement recommendations. Customers who take tests receive 20% off Solgar supplements, creating a commission/referral revenue stream. Eligible customers also receive $0 dietitian session with partner.
3. Enterprise Solutions: B2B offerings for professionals (nutritionists, dietitians, longevity clinics, sport coaches) and employers through dedicated /for-professionals and /for-employers channels.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Biostarks sells at-home dried blood spot biomarker test panels (Nutrition, Longevity NAD+, Metabolic Health, Sport Performance) that customers self-collect and return to Biostarks' CLIA-certified Swiss laboratory, where samples are analyzed via proprietary high-resolution mass spectrometry. Results are delivered as AI-assisted personalized wellness reports covering 30+ to 39+ biomarkers spanning vitamins, minerals, hormones, fatty acids, NAD+, and metabolic markers, with biomarker-guided supplement recommendations through the Solgar partnership.

Product overview

Biostarks offers a suite of at-home biomarker testing products powered by mass spectrometry technology. The product portfolio includes four core test panels: Nutrition Panel (30+ biomarkers, $199), Metabolic Health Panel (39+ biomarkers, $299), Longevity NAD+ Panel (4 biomarkers, $199), and Sport Performance Panel (currently sold out, $199). All panels use at-home dried blood spot collection and are FSA/HSA eligible. The platform is complemented by the Solgar x Biostarks commercial partnership for supplement recommendations, and the Open Labs feature for importing third-party lab reports. Results are delivered via an online platform with personalized wellness insights. The company operates its own CLIA-certified laboratory in Switzerland.

Differentiator

Problem solved

Functional benefit

Products and services

• Nutrition Panel

Quantifiable outcome

• 88% of BIOSTARKS users uncover at least one actionable insight from testing
• +5 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Partnerships

Two partnerships are on record, tiered flagship.

• SolgarflagshipGTM or Marketing Partner · 27 March 2026Solgar x Biostarks collaboration combines Biostarks' laboratory-grade biomarker testing with Solgar's gold-standard supplements. Customers measure biomarkers, receive personalized reports and health recommendations, then choose Solgar supplements tailored to their results. Biostarks customers unlock 20% off all Solgar supplements and access to $0 dietitian sessions. This is a flagship commercial partnership with co-branded marketing and integrated customer journey.
• Nestlé Health ScienceflagshipStrategic or Co-development Partner · 27 March 2026Biostarks announced commercial collaboration with Nestlé Health Science to scale biomarker-led nutrition—making nutrition measurable, personalized, and trackable over time through a simple loop: baseline → intervention → retest → optimize. This represents a major strategic partnership to expand biomarker-guided nutrition offerings and distribution.

Scale indicators4 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Everlywell: Leading DTC home health testing company offering a broad menu of at-home test kits (hormones, metabolism, nutrition). Shares Biostarks' e-commerce-led GTM and at-home collection model targeting similar consumer profiles.
• OmegaQuant Analytics: Specialty lab offering omega-3 index and other fatty acid biomarker testing using dried blood spot methodology. Closely comparable analytical testing approach and biomarker categories included in Biostarks' panels.
• Thorne HealthTech: Premium supplement brand with biomarker testing offering (OneGeno, TruDiagnostic partnership) and a target customer very similar to Biostarks. Owned by Nestlé Health Science — Biostarks' flagship partner — making it the most strategically aligned peer.
• Function Health: DTC at-home preventive health testing platform offering broad biomarker panels through partnerships with clinical labs. Directly competes with Biostarks for health-conscious consumers seeking comprehensive blood-based wellness insights.
• InsideTracker: Personalized nutrition and biomarker testing company that analyzes blood biomarkers to deliver lifestyle and supplement recommendations. Closely comparable to Biostarks across product, target customer (longevity/fitness-focused consumers), and recommendation-driven monetization.
• Viome Life Sciences: Microbiome and nutrition testing company selling DTC test kits with personalized food and supplement recommendations. Comparable closed-loop monetization model and consumer target (longevity/wellness enthusiasts).
• Precision Analytical (DUTCH Test): Specialty hormone and metabolite testing company using dried urine and dried blood spots with clinician-oriented reports. Comparable specialty biomarker analytical testing focus, though more clinician-distributed vs. Biostarks' consumer-DTC tilt.

Broad incumbents

• Quest Diagnostics: Large national clinical laboratory network offering comprehensive wellness and nutritional biomarker panels through B2C and physician channels. Comparable medical laboratory infrastructure at scale but lacks Biostarks' DTC convenience and at-home model.
• Genova Diagnostics: Specialty clinical diagnostics lab offering extensive panels including nutritional, hormonal, and inflammatory biomarkers. Operates broadly across healthcare practitioners, overlapping with Biostarks' professional channel but with a B2B-led motion rather than DTC.

Emerging players

• Levels Health: Consumer metabolic health platform using continuous glucose monitoring with personalized nutrition insights. Overlaps with Biostarks' Metabolic Health panel and GLP-1 companion positioning, though using CGM rather than blood spot analytics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biostarks

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biostarks